Combination drug for treating cervical cancer

A cervical cancer and drug technology, applied in the directions of drug combination, active ingredients of hydroxyl compounds, antitumor drugs, etc., can solve the problems of limited efficacy, and achieve the effects of low price, good antitumor effect and convenient use

Inactive Publication Date: 2011-04-13
ANHUI PROVINCIAL HOSPITAL
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Clinical data show that the efficacy of single use of ATRA is also very limited

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Combination drug for treating cervical cancer
  • Combination drug for treating cervical cancer
  • Combination drug for treating cervical cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0023] (1) Preparation processing

[0024] Non-limiting examples are as follows:

[0025] 1. Tablet

[0026] Get VPA and ATRA and adjuvant dextrin, ethanol, microcrystalline cellulose, carboxymethyl starch sodium, and magnesium stearate are processed tablet with wet granulation tabletting method, make every contain VPA100mg, ATRA10mg. Oral twice, three tablets each time.

[0027] 2. Capsules

[0028] Take VPA and ATRA by doubling dilution method, mix with dry starch, lactose, talcum powder, sodium lauryl sulfate, etc., and pour 2 # Capsules, each containing VPA0.1g, ATRA10mg. Oral three times, two capsules each time.

[0029] 3. Spray

[0030] Take VPA and ATRA together with trimethicone, cellulose derivatives, organic solvents, propellants and water processing sprays, and each ml contains 0.6g of VPA and 60mg of ATRA.

[0031] 4. Paint

[0032] Take VPA and ATRA together with cellulose derivatives, organic solvent and water processing paint, and each gram of paint con...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a combination drug for treating cervical cancer, which is a preparation processed by mixing 85 to 95 percent of sodium valproate and 5 to 15 percent of all-trans retinoic acid, comprising an oral preparation, or external preparation, or vaginal suppository allowed by pharmacy. External cyto-inhibition experiment shows that the inhibition ratio of the combination drug is 56 percent which is higher than that of a cis-platinum group of 41 percent, an ATRA group of 30 percent and a VPA group of 1 percent. Animal experiments show that the effect of the combination drug for inhibiting tumor growth is obviously superior than the effect of monotherapy the VPA and the oral cis-platinum.

Description

1. Technical field [0001] The invention relates to a pharmaceutical composition, specifically a combination medicine for treating cervical cancer. 2. Background technology [0002] Cervical cancer is still the malignant tumor with the highest morbidity and mortality of female reproductive tract in developing countries, and the incidence is younger and rising. There are 470,000 new cases in the world every year, more than 110,000 new cases in my country, and 20,000 to 30,000 women die of cervical cancer every year. The occurrence and development of cervical cancer is a relatively slow process, from cervical intraepithelial neoplasia (CIN) grade I, II, III to carcinoma in situ and invasive carcinoma of the cervix, it takes more than 10 years. There are three main traditional treatment methods for cervical cancer: surgery, radiotherapy, and chemotherapy, but these three main treatment methods have certain limitations. Surgical treatment is mainly used for stage Ib-IIa patient...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/203A61K31/19A61P35/00
Inventor 凌斌冯定庆曹振平周颖朱园园李彩荣李敏刘巧刘然
Owner ANHUI PROVINCIAL HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap